Approximate  ||| S:0 E:12 ||| JJ
entropy  ||| S:12 E:20 ||| NN
of  ||| S:20 E:23 ||| IN
electrocardiogram  ||| S:23 E:41 ||| JJ
signals  ||| S:41 E:49 ||| NNS
in  ||| S:49 E:52 ||| IN
atrial  ||| S:52 E:59 ||| FW
fibrillation  ||| S:59 E:72 ||| FW
Atrial  ||| S:72 E:79 ||| FW
fibrillation  ||| S:79 E:92 ||| FW
( ||| S:92 E:93 ||| -LRB-
Af ||| S:93 E:95 ||| NNP
)  ||| S:95 E:97 ||| -RRB-
is  ||| S:97 E:100 ||| VBZ
a  ||| S:100 E:102 ||| DT
common  ||| S:102 E:109 ||| JJ
arrhythmia  ||| S:109 E:120 ||| NN
and  ||| S:120 E:124 ||| CC
disorder  ||| S:124 E:133 ||| NN
of  ||| S:133 E:136 ||| IN
the  ||| S:136 E:140 ||| DT
rhythm  ||| S:140 E:147 ||| NN
of  ||| S:147 E:150 ||| IN
electrical  ||| S:150 E:161 ||| JJ
activation  ||| S:161 E:172 ||| NN
of  ||| S:172 E:175 ||| IN
the  ||| S:175 E:179 ||| DT
cardiac  ||| S:179 E:187 ||| JJ
atria ||| S:187 E:192 ||| NN
.  ||| S:192 E:194 ||| .
There  ||| S:194 E:200 ||| EX
is  ||| S:200 E:203 ||| VBZ
a  ||| S:203 E:205 ||| DT
high  ||| S:205 E:210 ||| JJ
risk  ||| S:210 E:215 ||| NN
of  ||| S:215 E:218 ||| IN
thromboembolism  ||| S:218 E:234 ||| NN
in  ||| S:234 E:237 ||| IN
patients  ||| S:237 E:246 ||| NNS
with  ||| S:246 E:251 ||| IN
Af ||| S:251 E:253 ||| NNP
.  ||| S:253 E:255 ||| .
Therefore ||| S:255 E:264 ||| RB
,  ||| S:264 E:266 ||| ,
it  ||| S:266 E:269 ||| PRP
is  ||| S:269 E:272 ||| VBZ
an  ||| S:272 E:275 ||| DT
indication  ||| S:275 E:286 ||| NN
for  ||| S:286 E:290 ||| IN
anticoagulant  ||| S:290 E:304 ||| JJ
therapy ||| S:304 E:311 ||| NN
.  ||| S:311 E:313 ||| .
The  ||| S:313 E:317 ||| DT
approximate  ||| S:317 E:329 ||| JJ
entropy  ||| S:329 E:337 ||| NNS
( ||| S:337 E:338 ||| -LRB-
ApEn ||| S:338 E:342 ||| NNP
)  ||| S:342 E:344 ||| -RRB-
of  ||| S:344 E:347 ||| IN
electrocardiogram  ||| S:347 E:365 ||| NNS
( ||| S:365 E:366 ||| -LRB-
ECG ||| S:366 E:369 ||| NNP
)  ||| S:369 E:371 ||| -RRB-
signals  ||| S:371 E:379 ||| NNS
was  ||| S:379 E:383 ||| VBD
calculated  ||| S:383 E:394 ||| VBN
in  ||| S:394 E:397 ||| IN
29  ||| S:397 E:400 ||| CD
subjects  ||| S:400 E:409 ||| NNS
without  ||| S:409 E:417 ||| IN
arrhythmia  ||| S:417 E:428 ||| NN
and  ||| S:428 E:432 ||| CC
12  ||| S:432 E:435 ||| CD
patients  ||| S:435 E:444 ||| NNS
with  ||| S:444 E:449 ||| IN
chronic  ||| S:449 E:457 ||| JJ
Af ||| S:457 E:459 ||| NNP
.  ||| S:459 E:461 ||| .
The  ||| S:461 E:465 ||| DT
mean  ||| S:465 E:470 ||| JJ
ApEn  ||| S:470 E:475 ||| NN
in  ||| S:475 E:478 ||| IN
the  ||| S:478 E:482 ||| DT
group  ||| S:482 E:488 ||| NN
without  ||| S:488 E:496 ||| IN
arrhythmia  ||| S:496 E:507 ||| NN
was  ||| S:507 E:511 ||| VBD
0.347  ||| S:511 E:517 ||| CD
+ ||| S:517 E:518 ||| CD
/ ||| S:518 E:519 ||| CD
-  ||| S:519 E:521 ||| :
0.119 ||| S:521 E:526 ||| CD
,  ||| S:526 E:528 ||| ,
and  ||| S:528 E:532 ||| CC
that  ||| S:532 E:537 ||| IN
of  ||| S:537 E:540 ||| IN
the  ||| S:540 E:544 ||| DT
chronic  ||| S:544 E:552 ||| JJ
Af  ||| S:552 E:555 ||| JJ
group  ||| S:555 E:561 ||| NN
was  ||| S:561 E:565 ||| VBD
0.556  ||| S:565 E:571 ||| CD
+ ||| S:571 E:572 ||| CD
/ ||| S:572 E:573 ||| CD
-  ||| S:573 E:575 ||| :
0.169 ||| S:575 E:580 ||| CD
.  ||| S:580 E:582 ||| .
ApEn  ||| S:582 E:587 ||| NNP
was  ||| S:587 E:591 ||| VBD
significantly  ||| S:591 E:605 ||| RB
higher  ||| S:605 E:612 ||| JJR
in  ||| S:612 E:615 ||| IN
the  ||| S:615 E:619 ||| DT
chronic  ||| S:619 E:627 ||| JJ
Af  ||| S:627 E:630 ||| JJ
group  ||| S:630 E:636 ||| NN
than  ||| S:636 E:641 ||| IN
in  ||| S:641 E:644 ||| IN
the  ||| S:644 E:648 ||| DT
no  ||| S:648 E:651 ||| DT
arrhythmia  ||| S:651 E:662 ||| JJ
group  ||| S:662 E:668 ||| NN
( ||| S:668 E:669 ||| -LRB-
p  ||| S:669 E:671 ||| FW
< ||| S:671 E:673 ||| SYM
0.002 ||| S:673 E:678 ||| FW
) ||| S:678 E:679 ||| -RRB-
.  ||| S:679 E:681 ||| .
The  ||| S:681 E:685 ||| DT
average  ||| S:685 E:693 ||| JJ
ApEn  ||| S:693 E:698 ||| NN
was  ||| S:698 E:702 ||| VBD
significantly  ||| S:702 E:716 ||| RB
higher  ||| S:716 E:723 ||| JJR
in  ||| S:723 E:726 ||| IN
the  ||| S:726 E:730 ||| DT
group  ||| S:730 E:736 ||| NN
not  ||| S:736 E:740 ||| RB
administered  ||| S:740 E:753 ||| VBN
anti-arrhythmic  ||| S:753 E:769 ||| JJ
drugs  ||| S:769 E:775 ||| NNS
( ||| S:775 E:776 ||| -LRB-
0.687  ||| S:776 E:782 ||| NNP
+ ||| S:782 E:783 ||| NNP
/ ||| S:783 E:784 ||| NNP
-  ||| S:784 E:786 ||| :
0.033 ||| S:786 E:791 ||| CD
)  ||| S:791 E:793 ||| -RRB-
than  ||| S:793 E:798 ||| IN
that  ||| S:798 E:803 ||| DT
in  ||| S:803 E:806 ||| IN
the  ||| S:806 E:810 ||| DT
group  ||| S:810 E:816 ||| NN
administered  ||| S:816 E:829 ||| VBN
anti-arrhythmic  ||| S:829 E:845 ||| JJ
drugs  ||| S:845 E:851 ||| NNS
( ||| S:851 E:852 ||| -LRB-
0.516  ||| S:852 E:858 ||| NNP
+ ||| S:858 E:859 ||| NNP
/ ||| S:859 E:860 ||| NNP
-  ||| S:860 E:862 ||| :
0.209 ||| S:862 E:867 ||| CD
)  ||| S:867 E:869 ||| -RRB-
( ||| S:869 E:870 ||| -LRB-
p  ||| S:870 E:872 ||| CD
< ||| S:872 E:874 ||| SYM
0.05 ||| S:874 E:878 ||| CD
) ||| S:878 E:879 ||| -RRB-
.  ||| S:879 E:881 ||| .
We  ||| S:881 E:884 ||| PRP
found  ||| S:884 E:890 ||| VBD
that  ||| S:890 E:895 ||| IN
ApEn  ||| S:895 E:900 ||| NNP
was  ||| S:900 E:904 ||| VBD
effective  ||| S:904 E:914 ||| JJ
in  ||| S:914 E:917 ||| IN
evaluating  ||| S:917 E:928 ||| VBG
the  ||| S:928 E:932 ||| DT
nonlinear  ||| S:932 E:942 ||| JJ
property  ||| S:942 E:951 ||| NN
and  ||| S:951 E:955 ||| CC
ApEn  ||| S:955 E:960 ||| JJ
of  ||| S:960 E:963 ||| IN
ECG  ||| S:963 E:967 ||| NNP
signals ||| S:967 E:974 ||| NNS
,  ||| S:974 E:976 ||| ,
enabling  ||| S:976 E:985 ||| VBG
assessment  ||| S:985 E:996 ||| NN
of  ||| S:996 E:999 ||| IN
the  ||| S:999 E:1003 ||| DT
randomness  ||| S:1003 E:1014 ||| NN
of  ||| S:1014 E:1017 ||| IN
chronic  ||| S:1017 E:1025 ||| JJ
Af ||| S:1025 E:1027 ||| NNP
.  ||| S:1027 E:1029 ||| .
